EPRX Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. (EPRX) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| OrbiMed Advisors Growth Healthcare | New | +269.0K | — | $1.8M | 0.0% | 59 |
| MILLENNIUM MANAGEMENT LLC | New | +441.6K | — | $2.9M | 0.0% | 59 |
| Qube Research & Technologies Ltd Quant | New | +34.2K | — | $226.3K | 0.0% | 55 |
| CITADEL ADVISORS LLC Quant | Increased | +271.8K | +118.1% | $1.8M | 0.0% | 54 |
| Hudson Bay Capital Management Event | Sold Out | -92.3K | -100.0% | $610.4K | 0.0% | 53 |
| TWO SIGMA INVESTMENTS, LP Quant | Increased | +210.3K | +1947.1% | $1.4M | 0.0% | 53 |
| Brevan Howard Capital Management Macro | New | +34.8K | — | $229.8K | 0.0% | 49 |
| Woodline Partners LP Long/Short | Increased | +306.3K | +69.5% | $2.0M | 0.0% | 42 |
| Point72 Asset Management, L.P. | Reduced | -237.3K | -24.5% | $1.6M | 0.0% | 37 |
| Rubric Capital Management Event | Increased | +176.3K | +25.5% | $1.2M | 0.1% | 36 |
Most significant buyers
By move score, not size.
- OrbiMed Advisors
- MILLENNIUM MANAGEMENT LLC
- Qube Research & Technologies Ltd
- CITADEL ADVISORS LLC
- TWO SIGMA INVESTMENTS, LP
Most significant sellers
By move score, not size.
- Hudson Bay Capital Management
- Point72 Asset Management, L.P.
- Boothbay Fund Management
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| OrbiMed Advisors | 2 | 269.0K | 0 | +269.0K | — | 0.0% | New | 59 |
| MILLENNIUM MANAGEMENT LLC | 2 | 441.6K | 0 | +441.6K | — | 0.0% | New | 59 |
| Qube Research & Technologies Ltd | 2 | 34.2K | 0 | +34.2K | — | 0.0% | New | 55 |
| CITADEL ADVISORS LLC | 1 | 502.0K | 230.2K | +271.8K | +118.1% | 0.0% | Increased | 54 |
| Hudson Bay Capital Management | 3 | 0 | 92.3K | -92.3K | -100.0% | 0.0% | Sold Out | 53 |
| TWO SIGMA INVESTMENTS, LP | 2 | 221.1K | 10.8K | +210.3K | +1947.1% | 0.0% | Increased | 53 |
| Brevan Howard Capital Management | 3 | 34.8K | 0 | +34.8K | — | 0.0% | New | 49 |
| Woodline Partners LP | 2 | 746.9K | 440.6K | +306.3K | +69.5% | 0.0% | Increased | 42 |
| Point72 Asset Management, L.P. | 1 | 730.3K | 967.6K | -237.3K | -24.5% | 0.0% | Reduced | 37 |
| Rubric Capital Management | 1 | 867.4K | 691.2K | +176.3K | +25.5% | 0.1% | Increased | 36 |
| Affinity Asset Advisors | 2 | 1.7M | 1.6M | +61.0K | +3.8% | 0.5% | Increased | 29 |
| Boothbay Fund Management | 4 | 212.7K | 323.8K | -111.2K | -34.3% | 0.0% | Reduced | 26 |
| Balyasny Asset Management L.P. | 2 | 1.4M | 1.4M | +15 | +0.0% | 0.0% | Increased | 26 |
| Alyeska Investment Group, L.P. | 2 | 375.0K | 375.0K | 0 | +0.0% | 0.0% | Unchanged | 20 |
| MARSHALL WACE, LLP | 2 | 158.1K | 158.1K | 0 | +0.0% | 0.0% | Unchanged | 20 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.